225 related articles for article (PubMed ID: 24075770)
1. Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist.
Taub R; Chiang E; Chabot-Blanchet M; Kelly MJ; Reeves RA; Guertin MC; Tardif JC
Atherosclerosis; 2013 Oct; 230(2):373-80. PubMed ID: 24075770
[TBL] [Abstract][Full Text] [Related]
2. Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH.
Harrison SA; Bashir M; Moussa SE; McCarty K; Pablo Frias J; Taub R; Alkhouri N
Hepatol Commun; 2021 Apr; 5(4):573-588. PubMed ID: 33860116
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia.
Kelly MJ; Pietranico-Cole S; Larigan JD; Haynes NE; Reynolds CH; Scott N; Vermeulen J; Dvorozniak M; Conde-Knape K; Huang KS; So SS; Thakkar K; Qian Y; Banner B; Mennona F; Danzi S; Klein I; Taub R; Tilley J
J Med Chem; 2014 May; 57(10):3912-23. PubMed ID: 24712661
[TBL] [Abstract][Full Text] [Related]
4. Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome.
Angelin B; Kristensen JD; Eriksson M; Carlsson B; Klein I; Olsson AG; Chester Ridgway E; Ladenson PW
J Intern Med; 2015 Mar; 277(3):331-342. PubMed ID: 24754313
[TBL] [Abstract][Full Text] [Related]
5. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Harrison SA; Bashir MR; Guy CD; Zhou R; Moylan CA; Frias JP; Alkhouri N; Bansal MB; Baum S; Neuschwander-Tetri BA; Taub R; Moussa SE
Lancet; 2019 Nov; 394(10213):2012-2024. PubMed ID: 31727409
[TBL] [Abstract][Full Text] [Related]
6. Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
Luong XG; Stevens SK; Jekle A; Lin TI; Gupta K; Misner D; Chanda S; Mukherjee S; Williams C; Stoycheva A; Blatt LM; Beigelman LN; Symons JA; Raboisson P; McGowan D; Vandyck K; Deval J
PLoS One; 2020; 15(12):e0240338. PubMed ID: 33306682
[TBL] [Abstract][Full Text] [Related]
7. Effects of Thyrotropin on Peripheral Thyroid Hormone Metabolism and Serum Lipids.
Beukhof CM; Massolt ET; Visser TJ; Korevaar TIM; Medici M; de Herder WW; Roeters van Lennep JE; Mulder MT; de Rijke YB; Reiners C; Verburg FA; Peeters RP
Thyroid; 2018 Feb; 28(2):168-174. PubMed ID: 29316865
[TBL] [Abstract][Full Text] [Related]
8. Thyroxine replacement therapy and circulating lipid concentrations.
Franklyn JA; Daykin J; Betteridge J; Hughes EA; Holder R; Jones SR; Sheppard MC
Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
[TBL] [Abstract][Full Text] [Related]
9. The influence of equol on the hypothalamic-pituitary-thyroid axis and hepatic lipid metabolic parameters in adult male rats.
Loutchanwoot P; Srivilai P; Jarry H
Life Sci; 2015 May; 128():1-7. PubMed ID: 25744395
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol.
Bays HE; McKenney JM; Dujovne CA; Schrott HG; Zema MJ; Nyberg J; MacDougall DE;
Am J Cardiol; 2003 Sep; 92(5):538-43. PubMed ID: 12943873
[TBL] [Abstract][Full Text] [Related]
11. Excess iodine and high-fat diet combination modulates lipid profile, thyroid hormone, and hepatic LDLr expression values in mice.
Han H; Xin P; Zhao L; Xu J; Xia Y; Yang X; Sun X; Hao L
Biol Trace Elem Res; 2012 Jun; 147(1-3):233-9. PubMed ID: 22222482
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.
Ballantyne CM; Pazzucconi F; Pintó X; Reckless JP; Stein E; McKenney J; Bortolini M; Chiang YT
Clin Ther; 2001 Feb; 23(2):177-92. PubMed ID: 11293552
[TBL] [Abstract][Full Text] [Related]
13. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study.
Tognini S; Polini A; Pasqualetti G; Ursino S; Caraccio N; Ferdeghini M; Monzani F
Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788
[TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists: importance of liver selectivity in drug discovery.
Takahashi N; Asano Y; Maeda K; Watanabe N
Biol Pharm Bull; 2014; 37(7):1103-8. PubMed ID: 24989002
[TBL] [Abstract][Full Text] [Related]
15. A mechanistic model of effects of dioxin on thyroid hormones in the rat.
Kohn MC; Sewall CH; Lucier GW; Portier CJ
Toxicol Appl Pharmacol; 1996 Jan; 136(1):29-48. PubMed ID: 8560478
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies.
Hunninghake DB
Am J Cardiol; 1998 Aug; 82(4B):26J-31J. PubMed ID: 9737643
[TBL] [Abstract][Full Text] [Related]
17. Randomized dose-response study of rosuvastatin in Japanese patients with hypercholesterolemia.
Saito Y; Goto Y; Dane A; Strutt K; Raza A
J Atheroscler Thromb; 2003; 10(6):329-36. PubMed ID: 15037821
[TBL] [Abstract][Full Text] [Related]
18. Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia.
Li JJ; Chen MZ; Chen X; Fang CH
Clin Cardiol; 2003 Oct; 26(10):472-6. PubMed ID: 14579918
[TBL] [Abstract][Full Text] [Related]
19. Effects of growth hormone on serum lipids and lipoproteins: possible significance of increased peripheral conversion of thyroxine to triiodothyronine.
Wolthers T; Lemming L; Grøfte T; Møller N; Christiansen JS; Klausen IC; Jørgensen JO
Metabolism; 1996 Aug; 45(8):1016-20. PubMed ID: 8769362
[TBL] [Abstract][Full Text] [Related]
20. Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats.
Wong H; Lehman-McKeeman LD; Grubb MF; Grossman SJ; Bhaskaran VM; Solon EG; Shen HS; Gerson RJ; Car BD; Zhao B; Gemzik B
Toxicol Sci; 2005 Apr; 84(2):232-42. PubMed ID: 15673846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
